The lack of regular, clear communication from the Trump administration on the bird flu outbreak has made it unnervingly ...

The most expensive home ever sold in Boulder, Colorado, is a modern five-bedroom manse with Flatiron views that just changed ...

SSDI to the standard of care for melanoma screening among patients at high-risk increased the number of excisions performed.

As a shopping editor, I will be the first to tell you that the beauty tech industry is a beast. These days, it feels like ...

Using the blood of a man with a unique snakebite history, researchers developed an antivenom cocktail that neutralized toxins ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

Gilead Sciences offers steady dividend growth with a 2.99% yield. Read why the analyst nonetheless has a neutral rating on ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

A biotech company is suing to block Merck & Co. from launching an easier-to-use version of its blockbuster cancer treatment ...

The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T-cell ...

Vir Biotechnology had a negative net margin of 678.40% and a negative return on equity of 36.71%. The business had revenue of $12.37 million for the quarter, compared to analyst estimates of $8.14 ...